Clinical Trial Update: Evaluate Safety and Efficacy of ABT-335 in Combination With Atorvastatin in Subjects With Multiple Abnormal Lipid Levels in the Blood [Phase 3]

View source ↗

Summary

A Phase 3 trial evaluated the safety and efficacy of ABT-335 in combination with atorvastatin in subjects with mixed dyslipidemia and coronary heart disease; re…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronary Heart Disease
• Mixed Dyslipidemia

Drugs mentioned

• ABT-335
• atorvastatin (atorvastatin)

Snippet

Sponsor: Abbott | Conditions: Mixed Dyslipidemia, Coronary Heart Disease | Phase 3 | Status: COMPLETED | Results posted: 2009-03-25